Menu
Back to Journals » Drug Design, Development and Therapy » Volume 16
Corrigendum
Switching from a Non-Protease Inhibitor-Based Regimen to the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice [Corrigendum]
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 3,964 | Dovepress* | 3,913+ | 74 | 3,987 | |
| PubMed Central* | 51 | 39 | 90 | ||
| Totals | 3,964 | 113 | 4,077 | ||
| *Since 27 October 2022 | |||||
View citations on PubMed Central and Google Scholar